• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Cedars Sinai Launches COVID-19 Recovery Program

by Jasmine Pennic 01/26/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Cedars Sinai Launches COVID-19 Recovery Program

What You Should Know:

– Patients in the Cedars-Sinai COVID-19 Recovery Program receive a comprehensive in-person evaluation with an expert in infectious diseases or pulmonary medicine who can refer them to a network of specialists.


Cedars-Sinai, today announce the launch of the COVID-19 Recovery Program to meet the needs of a growing number of COVID-19 patients who experience lingering symptoms weeks and even months after physicians say they are virus-free.

COVID-19 Recovery Program Overview

Patients recovering from COVID-19 suffer from physical symptoms such as shortness of breath, continued loss of taste or smell, dizziness or headaches, to cognitive symptoms including fatigue, brain fog, or increased anxiety or depression. In response to this, Cedars-Sinai developed the COVID-19 Recovery Program to connect patients who are experiencing persistent symptoms after COVID-19 to a network of specialists in order to provide the most comprehensive and best care available based on the latest developing understanding of the disease. In addition, patients can also opt to participate in clinical trials and contribute to a deeper understanding of long-term effects of COVID-19. 

To amplify its efforts, the COVID-19 Recovery Program works closely with two other Cedars-Sinai efforts:

– The Smidt Heart Institute’s Post-COVID-19 Cardiology Program, which enrolls patients who have been diagnosed with a heart issue associated with post-COVID-19 recovery.

– The Cedars-Sinai Department of Medicine’s Post-ICU Clinic, which focuses primarily on respiratory and neurological problems that develop in some intensive care unit patients after they are discharged.

“Given the sheer number of people worldwide who have had COVID-19–more than 90 million–if even 1% experience symptoms beyond three months, that is a huge number of patients who need help,” said program co-director Catherine Le, MD, an infectious disease specialist with Cedars-Sinai Medical Group. “For some patients, we are the first physicians they’ve seen in person since their diagnosis. Even if we don’t have all the answers right now, it puts many of our patients at ease to speak with an expert and get a complete evaluation.”

Eligibility Requirements

To be eligible for treatment in the program, patients must:

– Be referred by a physician.

– Have had COVID-19, confirmed by a positive test result.

– Be experiencing persistent symptoms.


  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Cedars-Sinai, Clinical Trials, Coronavirus (COVID-19), Depression, Heart, MD, medical group, physicians

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Most-Read

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |